These observations could be of clinical relevance in obesity-related metabolic disorders, especially because multiple nonsynonymous mutations in CREBH have been reported in human patients with extreme hypertriglyceridemia (8). This evidence concerns the gene CREB3L3 and hypertriglyceridemia.